HELP     Sign In
Search

Relevance to Autism

Mice with a mutated version of the thyroid hormone receptor alpha displayed a depressive and anxious phenotype that was alleviated with continuous T3-substitution therapy (Pilhatsch et al., 2010).

Molecular Function

The protein encoded by this gene is a nuclear hormone receptor for triiodothyronine. It is one of the several receptors for thyroid hormone, and has been shown to mediate the biological activities of thyroid hormone. Knockout studies in mice suggest that the different receptors, while having certain extent of redundancy, may mediate different functions of thyroid hormone.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Increased depressive behaviour in mice harboring the mutant thyroid hormone receptor alpha 1.
Support
Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks.
ASD
Support
Analysis and functional characterization of sequence variations in ligand binding domain of thyroid hormone receptors in autism spectrum disorder (...
ASD
Support
Whole-genome sequencing of quartet families with autism spectrum disorder.
ASD
Support
Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes
ASD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN421R001 
 missense_variant 
 c.1150C>T 
 p.Arg384Cys 
 De novo 
  
 Multiplex 
 GEN421R002 
 splice_site_variant 
 c.54-1G>A 
  
 Familial 
 Paternal 
 Multiplex 
 GEN421R003 
 frameshift_variant 
 c.1280dup 
 p.Ala428GlyfsTer8 
 Familial 
 Maternal 
  

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
17
Duplication
 1
 
17
Duplication
 1
 
17
Deletion
 2
 

Model Summary

Unliganded Thra leads to a depressive and anxious phenotype, which is responsive to continuous T3-substitution and that an iatrogeneously induced hyperthyreoidism by continuous T3-administration leads to a hypolocomotive and depressive phenotype.

References

Type
Title
Author, Year
Primary
Increased depressive behaviour in mice harboring the mutant thyroid hormone receptor alpha 1.

M_THRA_1_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Point mutation in Thra generated by site directecd mutagenesis in converting Codon 384 to encode a cysteine instead of an arginine.
Allele Type: Targeted (Point Mutation)
Strain of Origin: C57Bl6/NCrl
Genetic Background: Not Specified
ES Cell Line: Not Specified
Mutant ES Cell Line: Not Specified
Model Source: Not Specified

M_THRA_1_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
General locomotor activity1
Decreased
Description: Decreased horizontal locomotor activity
Exp Paradigm: Open field test
 Open field test
 3-4 months
Startle response: acoustic stimulus1
Decreased
Description: Decreased acoustic startle reflex in response to a stimulus of 120 db after administration of t3
Exp Paradigm: Response to 120 db acoustic startle stimulus after t3-substitution treatment
 Acoustic startle reflex test
 3-4 months
Startle response: acoustic stimulus1
Increased
Description: Increased acoustic startle reflex in response to a stimulus of 120 db
Exp Paradigm: Response to 120 db acoustic startle stimulus
 Acoustic startle reflex test
 3-4 months
Anxiety1
Increased
Description: Increased anxiety indicated by total time spent and shuttles to light compartment
Exp Paradigm: Light/dark box test
 Light-dark exploration test
 3-4 months
Anxiety1
Decreased
Description: Decreased anxiety behavior after administration of t3
Exp Paradigm: Light/dark box test after t3-substitution treatment
 Light-dark exploration test
 3-4 months
Cued or contextual fear conditioning1
Increased
Description: Increased helplessness evidenced by the number of escape shuttles and increased latency of escape
Exp Paradigm: Active avoidance behavior test for learned helplessness
 Active avoidance test
 3-4 months
Cued or contextual fear conditioning1
Decreased
Description: Decreased helplessness behavior after administration of t3
Exp Paradigm: Active avoidance behavior test for learned helplessness after t3-substitution treatment
 Active avoidance test
 3-4 months
General locomotor activity1
 No change
 Open field test
 3-4 months
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Immune response, Maternal behavior, Molecular profile, Neuroanatomy / ultrastructure / cytoarchitecture, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Social behavior



HELP
Copyright © 2017 MindSpec, Inc.